Boswellia extrait
Food supplement declared in France, declaration No 2023-10-182, decision dated 4 October 2023
Boswellia extrait is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- SAS LA COTENTINE
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Gélule
- Daily dose
- 6 gélules
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Enfants (de moins de 10 ans)
Declaration 190063, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Boswellia serrata Roxb. ex Colebr. | Résine | Extrait sec aqueux | 1.5 g |
Additives
Hydroxypropyl Méthyl Cellulose, E470b
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging
Label warnings
À conserver à l’abri de la chaleur et de l’humidité. Tenir hors de portée des jeunes enfants. Ne pas dépasser la dose conseillée. À consommer dans le cadre d’une alimentation variée et équilibrée et d’un mode de vie sain. Déconseillé chez la femme enceinte, allaitante et l’enfant de moins de 12 ans.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Boswellia extrait Floralpina, declared in 2023 : same declared composition
- Boswellia extrait MONSIEUR NICOLAS BASTIDE D IZARD, declared in 2022 : same declared composition
- Boswellia extrait MADAME DOLORES BELESTIN, declared in 2022 : same declared composition
- Boswellia extrait Floralpina, declared in 2017 : different composition: 0 ingredient(s) added, 2 missing
- Boswellia extrait SAS LA COTENTINE, declared in 2022, withdrawn from the market : different composition: 1 ingredient(s) added, 2 missing
- Boswellia extrait Floralpina, declared in 2022, withdrawn from the market : different composition: 1 ingredient(s) added, 1 missing